Comprehensive Proteomics Profiling of Myocardium Identifies Dysregulated Signaling Pathways in Hypertrophic Cardiomyopathy

被引：0
|
作者：
Lumish, Heidi S.
Liang, Lusha
Hasegawa, Kohei
Adlestein, Elizabeth
Swistel, Daniel
Maurer, Mathew S.
Reilly, Muredach P.
Sherrid, Mark
Shimada, Yuichi J.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13844
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Comprehensive Proteomics Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Severe Forms of Hypertrophic Cardiomyopathy
    Hartman, Heidi
    Sherrid, Mark
    Hasegawa, Kohei
    Adlestein, Elizabeth
    Swistel, Daniel
    Tower-Rader, Albree
    Fifer, Michael A.
    Topkara, Veli K.
    Maurer, Mathew S.
    Reilly, Muredach P.
    Shimada, Yuichi
    CIRCULATION, 2023, 148
  • [2] Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy
    Lumish, Heidi S.
    Sherrid, Mark V.
    Janssen, Paul M. L.
    Ferrari, Giovanni
    Hasegawa, Kohei
    Castillero, Estibaliz
    Adlestein, Elizabeth
    Swistel, Daniel G.
    Topkara, Veli K.
    Maurer, Mathew S.
    Reilly, Muredach P.
    Shimada, Yuichi J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (20) : 1999 - 2011
  • [3] Comprehensive Plasma Proteomics Profiling Identifies Signaling Pathways Dysregulated in Genotype-Positive versus GenotypeNegative Patients With Hypertrophic Cardiomyopathy
    Akita, Keitaro
    Hasegawa, Kohei
    Maurer, Mathew S.
    Rader, Albree Tower
    Fifer, Michael A.
    Topkara, Veli K.
    Reilly, Muredach P.
    Shimada, Yuichi
    CIRCULATION, 2023, 148
  • [4] Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways
    Liang, Lusha W.
    Hasegawa, Kohei
    Maurer, Mathew S.
    Reilly, Muredach P.
    Fifer, Michael A.
    Shimada, Yuichi J.
    CIRCULATION-HEART FAILURE, 2023, 16 (06) : E010010
  • [5] Proteomics Profiling Reveals Molecular Pathways Enriched in Hypertrophic Cardiomyopathy
    Shimada, Yuichi J.
    Hasegawa, Kohei
    Kochav, Stephanie M.
    Mohajer, Pouya
    Fifer, Michael A.
    Gerszten, Robert
    CIRCULATION, 2018, 138
  • [6] Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy
    Shimada, Yuichi J.
    Raita, Yoshihiko
    Liang, Lusha W.
    Maurer, Mathew S.
    Hasegawa, Kohei
    Fifer, Michael A.
    Reilly, Muredach P.
    CIRCULATION-HEART FAILURE, 2021, 14 (07) : 777 - 787
  • [7] Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
    Lee, C.
    Liang, L. W.
    Hasegawa, K.
    Maurer, M. S.
    Tower-Rader, A.
    Fifer, M. A.
    Reilly, M. P.
    Shimada, Y. J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1724 - 1724
  • [8] Signaling Pathways in Hypertrophic Cardiomyopathy: Will Proteomic Profiling Guide the Future?
    Aurora, Lindsey
    Wanderley Jr, Mauro R. B.
    JOURNAL OF CARDIAC FAILURE, 2024, 30 (03) : 473 - 475
  • [9] Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy
    Akita, Keitaro
    Maurer, Mathew S.
    Tower-Rader, Albree
    Fifer, Michael A.
    Shimada, Yuichi J.
    CIRCULATION-HEART FAILURE, 2025, 18 (01)
  • [10] Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population
    Lander, Bradley S.
    Zhao, Yanling
    Hasegawa, Kohei
    Maurer, Mathew S.
    Tower-Rader, Albree
    Fifer, Michael A.
    Reilly, Muredach P.
    Shimada, Yuichi J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345